News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
News By Date


Monday, August 29, 2016

Top Breaking News
With 11 Drugs in the Pipeline Already, Cash-Rich Moderna Eyes Another $600 Million
Bay Area Startup Arcus Biosciences Emerges With $120 Million
Massachusetts Cancer Biotech Mitra Biotech Scores $27.4 Million
AxoSim Leads a Biotech Startup Scene in New Orleans
2 Biotech Stocks Billionaire Investor George Soros Dumped. Should You?
Martin Shkreli Sells Remaining Stake of Bay Area's KaloBios (KBIO)
Aurobindo (AUROBINDOP.BO), Intas Pharma in Race to Buy Out Teva (TEVA)'s UK Biz for $1 Billion
Backlash Leads Mylan (MYL) to Launch First Generic EpiPen at Half the Price
CTI BioPharma's Pacritinib Shows Mixed Results in Phase III Test; Full Clinical Hold Still In Effect
FDA Issues Emergency Use of Roche (RHHBY)'s Zika Test
Taking a Closer Look at Nymox (NYMX)'s 'Overinflated' Prostate Drug Hype
Regeneron (REGN), Sanofi (SNY)'s Potential Blockbuster Praluent Passes Late-Stage Test
GlaxoSmithKline (GSK) Execs Set High Hopes for Game-Changing HIV Research Strategy
23andMe Ancestry Tests Allegedly Have Issues With People of Color
IMS Health and Quintiles (Q) Names Key Officers for Post-Merger Lineup

News from Around the Web

Press Releases
Seqirus Receives FDA Approval For AFLURIA QUADRIVALENT (Influenza Vaccine) For People 18 Years Of Age And Older
IMPAX Labs (IPXL) Issues Voluntary, Nationwide Recall For One Lot Of Lamotrigine Orally Disintegrating Tablet 200 Mg Due To The Potential For 100 Mg Blister Cards Being Packaged In 200 Mg Containers
Amgen (AMGN) Announces Positive Top-Line Results From Phase 3 Study Of Prolia (Denosumab) In Patients Receiving Glucocorticoid Therapy
AcelRx (ACRX) Presents Results From Phase 3 Study Of ARX-04 In The Emergency Department At The International Society For Burn Injuries
CardioCell Reports Positive Results From The First Phase Ila Clinical Trial Using IV Administration Of Stem Cells For Chronic Heart Failure Indications
Shionogi Presents Results From A Phase 2 Proof-Of-Concept Clinical Trial And Non-Clinical Studies Of S-033188, A Novel Cap-Dependent Endonuclease Inhibitor For Treatment Of Influenza
Tonix Pharma (TNXP) Announces Successful End-Of-Phase II Meeting With FDA For TNX-102 SL In Post-Traumatic Stress Disorder
Cerecor Inc. Announces Initiation Of Second CERC-501 Phase II Clinical Trial In Smokers
Kadmon Initiates Phase II Clinical Trial Evaluating Tesevatinib In Glioblastoma
Doctors Prescribe Diabetes Treatment Medications 15 Times More Than Obesity Drugs, The Obesity Society Study Finds
Elite Pharma (ELI) Announces Development And License Agreement With Sungen Pharma
Tetragenetics, Inc. Announces Another Strategic Partnership With A Top Ten Pharmaceutical Company
CEL-SCI (CVM) Announces The Closing Of Its $5 Million Registered Direct Offering
Enanta Pharmaceuticals, Inc. To Present At Two Upcoming Investor Conferences
Medtech Firm VistaMed to Create 200 New Jobs in Expansion
New Microscopy Technique Identifies And Quantifies Bacterial Infections In Minutes, ICFO-The Institute of Photonic Sciences Reveals
Activity Tracker Uses Heart Rate To Personalize Amount Of Exercise Needed To Prevent Death, European Society of Cardiology Reveals
Mind-Controlled Nanobots Release Drugs Inside Cockroaches, Bar-Ilan University Study Reveals
First Epigenetic Test To Diagnose Tumors Of Unknown Origin, IDIBELL-Bellvitge Biomedical Research Institute Study
Parkinson's Study Could Pave Way For Early Detection Test, University of Edinburgh Study Reveals
Medtronic (MDT) Shows Off 12-Month Data on Micra Leadless Pacemaker
Misonix Incorporated (MSON) CEO to Retire
MetaStat Announces Presentation Of Two Metasite Breast Studies At The 2016 San Antonio Breast Cancer Symposium